TC
DPLO

Truvestments Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Truvestments Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,000
Closed -$6K – 800
2019
Q1 		$6K Buy
+1,000
New +$10.3K ﹤0.01% 590
2018
Q3 		$19K Buy
+1,000
New +$21.3K 0.01% 526

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Truvestments Capital's DPLO Position: Q2 2019 in Review

Truvestments Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 1,000 shares — an estimated $6K sold.

Truvestments Capital first reported a position in DPLO in Q3 2018 and held it in 2 quarters. The position peaked at $19K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Truvestments Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Truvestments Capital sold 1,000 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $6K.
  • Truvestments Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 2 quarters.
  • Truvestments Capital's DIPLOMAT PHARMACY, INC. position peaked at $19K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Truvestments Capital's 13F filing for Q2 2019, filed 15 Jul 2019.